Arax Advisory Partners’s AdaptHealth AHCO Stock Holding History

Arax Advisory Partners’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.3K	Buy	4,925 +4,453	+943%	+$49.7K	﹤0.01%	3243
2026 Q1	$5.62K	Buy	472 +60	+15%	+$614	﹤0.01%	2728
2025 Q4	$4.1K	Sell	412 -8,077	-95%	-$77.1K	﹤0.01%	2956
2025 Q3	$76K	Buy	+8,489	New	+$78.6K	﹤0.01%	1645
2025 Q1	–	Sell	-112	Closed	-$1.07K	–	2669
2024 Q4	$1.07K	Sell	112 -508	-82%	-$5.14K	﹤0.01%	2165
2024 Q3	$6.96K	Hold	620	–	–	﹤0.01%	1562
2024 Q2	$6.2K	Buy	+620	New	+$6.3K	﹤0.01%	1493

Other funds holding AHCO

OCA

OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.11B AUM 38.38% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Arax Advisory Partners's AHCO Position: Q2 2026 in Review

Arax Advisory Partners increased its AdaptHealth (AHCO) stake by 943% in Q2 2026, buying an estimated $49.7K and bringing the position to 4,925 shares worth $51.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3243.

Arax Advisory Partners first reported a position in AHCO in Q2 2024 and has held it in 7 quarters since. The position peaked at $76K in Q3 2025. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

Arax Advisory Partners held 4,925 shares of AdaptHealth worth $51.3K as of Q2 2026.
Arax Advisory Partners bought 4,453 AdaptHealth shares in Q2 2026, an estimated $49.7K.
AdaptHealth made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3243 holding.
Arax Advisory Partners first reported a position in AdaptHealth in Q2 2024 and has held it in 7 quarters since.
Arax Advisory Partners's AdaptHealth position peaked at $76K in Q3 2025.
239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.